Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

ARBs don't stop atrial fibrillation recurrence

ARBs may not prevent atrial fibrillation from recurring, contrary to the results of early experimental studies, new US research suggests.

In a randomised controlled trial, 1,400 patients with atrial fibrillation were given either valsartan or placebo.

There was no significant difference in the recurrence of atrial fibrillation in patients in the valsartan and placebo groups. Atrial fibrillation recurred in 51.4% of the valsartan group compared with 52.1% in the placebo group.

New England Journal of Medicine

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say